Susquehanna International Group
AQST icon

Susquehanna International Group’s Aquestive Therapeutics AQST Stock Holding History

Susquehanna International Group’s Portfolio AQST Stock Details AQST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.97M Buy
956,500
+401,600
+72% +$1.63M ﹤0.01% 4680
2025
Q4 		$3.58M Buy
554,900
+398,400
+255% +$2.48M ﹤0.01% 4568
2025
Q3 		$875K Buy
156,500
+107,700
+221% +$466K ﹤0.01% 7665
2025
Q2 		$162K Buy
48,800
+4,600
+10% +$13.2K ﹤0.01% 11441
2025
Q1 		$128K Sell
44,200
-43,500
-50% -$132K ﹤0.01% 11348
2024
Q4 		$312K Sell
87,700
-342,100
-80% -$1.58M ﹤0.01% 9754
2024
Q3 		$2.14M Buy
429,800
+220,400
+105% +$858K ﹤0.01% 5142
2024
Q2 		$544K Sell
209,400
-131,600
-39% -$440K ﹤0.01% 8061
2024
Q1 		$1.45M Buy
341,000
+228,900
+204% +$762K ﹤0.01% 6080
2023
Q4 		$226K Buy
112,100
+50,300
+81% +$88.9K ﹤0.01% 10423
2023
Q3 		$94.6K Buy
61,800
+33,900
+122% +$58.3K ﹤0.01% 10969
2023
Q2 		$46K Buy
+27,900
New +$50.5K ﹤0.01% 11370
2022
Q2 		– Sell
-61,600
Closed -$161K – 12817
2022
Q1 		$161K Sell
61,600
-45,500
-42% -$133K ﹤0.01% 11488
2021
Q4 		$417K Buy
107,100
+42,900
+67% +$215K ﹤0.01% 9655
2021
Q3 		$280K Buy
64,200
+38,000
+145% +$149K ﹤0.01% 10749
2021
Q2 		$104K Sell
26,200
-17,900
-41% -$71.5K ﹤0.01% 12075
2021
Q1 		$229K Buy
+44,100
New +$235K ﹤0.01% 11148
2020
Q3 		– Sell
-115,500
Closed -$561K – 10503
2020
Q2 		$561K Buy
+115,500
New +$532K ﹤0.01% 7130

Other funds holding AQST

BCM
Bratton Capital Management Fort Worth, Texas $40.7M AUM 43.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Susquehanna International Group's AQST Position: Q1 2026 in Review

Susquehanna International Group reduced its Aquestive Therapeutics (AQST) stake by 43% in Q1 2026, selling an estimated $1.01M and leaving 337,635 shares worth $1.4M. The position accounts for ﹤0.01% of the portfolio, ranked #7064.

Susquehanna International Group first reported a position in AQST in Q4 2019 and has held it in 23 quarters since. The position peaked at $6.09M in Q3 2025. 179 funds tracked by Wall St. Rank hold AQST as of Q1 2026.

  • Susquehanna International Group held 337,635 shares of Aquestive Therapeutics worth $1.4M as of Q1 2026.
  • Susquehanna International Group sold 249,614 Aquestive Therapeutics shares in Q1 2026, an estimated $1.01M.
  • Aquestive Therapeutics made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #7064 holding.
  • Susquehanna International Group first reported a position in Aquestive Therapeutics in Q4 2019 and has held it in 23 quarters since.
  • Susquehanna International Group's Aquestive Therapeutics position peaked at $6.09M in Q3 2025.
  • 179 funds tracked by Wall St. Rank held Aquestive Therapeutics as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.